The role of glycosyltransferase enzyme GCNT3 in colon and ovarian cancer prognosis and chemoresistance
- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
2045-2322
- Extent
-
Online-Ressource
- Language
-
Englisch
- Notes
-
online resource.
- Bibliographic citation
-
The role of glycosyltransferase enzyme GCNT3 in colon and ovarian cancer prognosis and chemoresistance ; volume:8 ; number:1 ; day:31 ; month:5 ; year:2018 ; pages:1-13 ; date:12.2018
Scientific reports ; 8, Heft 1 (31.5.2018), 1-13, 12.2018
- Creator
-
Fernández, Lara P.
- Contributor
-
Sánchez-Martínez, Ruth
Vargas, Teodoro
Herranz, Jesús
Martín-Hernández, Roberto
Mendiola, Marta
Hardisson, David
Reglero, Guillermo
Feliu, Jaime
Redondo, Andrés
Ramírez de Molina, Ana
SpringerLink (Online service)
- DOI
-
10.1038/s41598-018-26468-4
- URN
-
urn:nbn:de:101:1-2018080515352987835876
- Rights
-
Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
15.08.2025, 7:21 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Fernández, Lara P.
- Sánchez-Martínez, Ruth
- Vargas, Teodoro
- Herranz, Jesús
- Martín-Hernández, Roberto
- Mendiola, Marta
- Hardisson, David
- Reglero, Guillermo
- Feliu, Jaime
- Redondo, Andrés
- Ramírez de Molina, Ana
- SpringerLink (Online service)
Other Objects (12)
Abnormal methylation characteristics predict chemoresistance and poor prognosis in advanced high-grade serous ovarian cancer
Tumor evolution and chemoresistance in ovarian cancer
Sox2 promotes expression of the ST6Gal-I glycosyltransferase in ovarian cancer cells
A signature based on glycosyltransferase genes provides a promising tool for the prediction of prognosis and immunotherapy responsiveness in ovarian cancer
Unveiling novel biomarkers for platinum chemoresistance in ovarian cancer
Identifying novel hypoxia-associated markers of chemoresistance in ovarian cancer
TGFBI promoter hypermethylation correlating with paclitaxel chemoresistance in ovarian cancer
Chemoresistance is mediated by ovarian cancer leader cells in vitro
The SP1-12LOX axis promotes chemoresistance and metastasis of ovarian cancer
Chemotherapy-induced hyaluronan production: a novel chemoresistance mechanism in ovarian cancer
Glycosyltransferase efficiently controls phenylpropanoid pathway
MAL gene overexpression as a marker of high-grade serous ovarian carcinoma stem-like cells that predicts chemoresistance and poor prognosis
Abnormal methylation characteristics predict chemoresistance and poor prognosis in advanced high-grade serous ovarian cancer
Tumor evolution and chemoresistance in ovarian cancer
Sox2 promotes expression of the ST6Gal-I glycosyltransferase in ovarian cancer cells
A signature based on glycosyltransferase genes provides a promising tool for the prediction of prognosis and immunotherapy responsiveness in ovarian cancer
Unveiling novel biomarkers for platinum chemoresistance in ovarian cancer
Identifying novel hypoxia-associated markers of chemoresistance in ovarian cancer
TGFBI promoter hypermethylation correlating with paclitaxel chemoresistance in ovarian cancer
Chemoresistance is mediated by ovarian cancer leader cells in vitro
The SP1-12LOX axis promotes chemoresistance and metastasis of ovarian cancer
Chemotherapy-induced hyaluronan production: a novel chemoresistance mechanism in ovarian cancer
Glycosyltransferase efficiently controls phenylpropanoid pathway
MAL gene overexpression as a marker of high-grade serous ovarian carcinoma stem-like cells that predicts chemoresistance and poor prognosis
Abnormal methylation characteristics predict chemoresistance and poor prognosis in advanced high-grade serous ovarian cancer
Tumor evolution and chemoresistance in ovarian cancer
Sox2 promotes expression of the ST6Gal-I glycosyltransferase in ovarian cancer cells
A signature based on glycosyltransferase genes provides a promising tool for the prediction of prognosis and immunotherapy responsiveness in ovarian cancer
Unveiling novel biomarkers for platinum chemoresistance in ovarian cancer
Identifying novel hypoxia-associated markers of chemoresistance in ovarian cancer
TGFBI promoter hypermethylation correlating with paclitaxel chemoresistance in ovarian cancer
Chemoresistance is mediated by ovarian cancer leader cells in vitro
The SP1-12LOX axis promotes chemoresistance and metastasis of ovarian cancer
Chemotherapy-induced hyaluronan production: a novel chemoresistance mechanism in ovarian cancer
Glycosyltransferase efficiently controls phenylpropanoid pathway